These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


52 related items for PubMed ID: 3052973

  • 1. Differential effect of inflammatory stimuli on murine plasma C4 and factor B concentrations.
    Garlepp MJ, Fritzler MJ, Hart DA.
    Clin Invest Med; 1988 Oct; 11(5):341-6. PubMed ID: 3052973
    [Abstract] [Full Text] [Related]

  • 2. Regulation of plasma complement C4 and factor b levels in murine systemic lupus erythematosus.
    Garlepp MJ, Hart DA, Fritzler MJ.
    J Clin Lab Immunol; 1989 Mar; 28(3):137-41. PubMed ID: 2738911
    [Abstract] [Full Text] [Related]

  • 3. Treatment of mice with indomethacin leads to the appearance of a 125,000 dalton plasma protein with the characteristics of an acute phase reactant.
    Hart DA, Mannerfeldt J, Babins E.
    J Clin Lab Immunol; 1987 Jun; 23(2):83-90. PubMed ID: 2442392
    [Abstract] [Full Text] [Related]

  • 4. Biosynthesis of C4 by mouse peritoneal macrophages. I. Characterization of an in vitro culture system and comparison of C4 synthesis by "low" vs "high" C4 strains.
    Newell SL, Shreffler DC, Atkinson JP.
    J Immunol; 1982 Aug; 129(2):653-9. PubMed ID: 6919567
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Age and lpr dependent induction of increased sensitivity to the toxic effects of lipopolysaccharide and indomethacin in MRL mice: evidence for RES activation during disease progression.
    Hart DA.
    J Clin Lab Immunol; 1988 Jul; 26(3):129-34. PubMed ID: 3230580
    [Abstract] [Full Text] [Related]

  • 7. Corynebacterium parvum- and Mycobacterium bovis Bacillus Calmette and Guerin-induced granuloma formation in mice lacking CD4 and CD8.
    Senaldi G, Shaklee CL, Mak TW, Ulich TR.
    Cell Immunol; 1999 May 01; 193(2):155-61. PubMed ID: 10222057
    [Abstract] [Full Text] [Related]

  • 8. Three cases of factor I deficiency: the effect of treatment with plasma.
    Møller Rasmussen J, Teisner B, Jepsen HH, Svehag SE, Knudsen F, Kirstein H, Buhl M.
    Clin Exp Immunol; 1988 Oct 01; 74(1):131-6. PubMed ID: 3219799
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Role of inflammatory neutrophils in antitumor effects induced by intraperitoneal administration of Corynebacterium parvum in mice.
    Lichtenstein AK, Berek J, Kahle J, Zighelboim J.
    Cancer Res; 1984 Nov 01; 44(11):5118-23. PubMed ID: 6488171
    [Abstract] [Full Text] [Related]

  • 13. Complement polymorphism, the major histocompatibility complex and associated diseases: a speculation.
    Porter RR.
    Mol Biol Med; 1983 Jul 01; 1(1):161-8. PubMed ID: 6679872
    [Abstract] [Full Text] [Related]

  • 14. Complement activation in acute coronary syndromes.
    Iltumur K, Karabulut A, Toprak G, Toprak N.
    APMIS; 2005 Mar 01; 113(3):167-74. PubMed ID: 15799759
    [Abstract] [Full Text] [Related]

  • 15. Anti-DNA autoreactivity in C4-deficient mice.
    Paul E, Pozdnyakova OO, Mitchell E, Carroll MC.
    Eur J Immunol; 2002 Sep 01; 32(9):2672-9. PubMed ID: 12207352
    [Abstract] [Full Text] [Related]

  • 16. Differential cytokine regulation of complement C3, C4, and factor B synthesis in human intestinal epithelial cell line, Caco-2.
    Andoh A, Fujiyama Y, Bamba T, Hosoda S.
    J Immunol; 1993 Oct 15; 151(8):4239-47. PubMed ID: 8409399
    [Abstract] [Full Text] [Related]

  • 17. Serum concentrations of C4 isotypes and factor B in type I C2 deficiency suggest haplotype-dependent quantitative expression of MHC class III complement genes.
    Truedsson L, Gullstrand B, Jönsson T, Klint C.
    Exp Clin Immunogenet; 1995 Oct 15; 12(2):66-73. PubMed ID: 7576717
    [Abstract] [Full Text] [Related]

  • 18. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
    Kaumaya PT, Kobs-Conrad S, Seo YH, Lee H, VanBuskirk AM, Feng N, Sheridan JF, Stevens V.
    J Mol Recognit; 1993 Jun 15; 6(2):81-94. PubMed ID: 7508238
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. C3, C4, factor B and HLA-DR alpha mRNA expression in renal biopsy specimens from patients with IgA nephropathy.
    Oren R, Laufer J, Goldberg I, Kopolovic J, Waldherr R, Passwell JH.
    Immunology; 1995 Dec 15; 86(4):575-83. PubMed ID: 8567024
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 3.